BiotechTube

Oral testosterone undecanoate (Andriol) + Placebo

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hypogonadism

Conditions

Hypogonadism, Androgens

Trial Timeline

Nov 1, 2001 → Jul 1, 2004

NCT ID
NCT00434824

About Oral testosterone undecanoate (Andriol) + Placebo

Oral testosterone undecanoate (Andriol) + Placebo is a phase 2 stage product being developed by Merck for Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT00434824. Target conditions include Hypogonadism, Androgens.

What happened to similar drugs?

6 of 19 similar drugs in Hypogonadism were approved

Approved (6) Terminated (3) Active (12)
✅Topical Testosterone SolutionEli LillyApproved
✅AndroGel® + PlaceboAbbVieApproved
✅AndroGel 1.62%AbbVieApproved
✅Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
✅NEBIDO + PLACEBOBayerApproved
✅JatenzoICON plc.Approved
🔄Testosterone Solution + Placebo SolutionEli LillyPhase 3

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00434824Phase 2Completed

Competing Products

20 competing products in Hypogonadism

See all competitors
ProductCompanyStageHype Score
Topical Testosterone SolutionEli LillyApproved
43
Testosterone Solution + Placebo SolutionEli LillyPhase 3
40
Testosterone MD-LotionEli LillyPhase 2
35
Testosterone MD-LotionEli LillyPhase 3
40
Testosterone MD-LotionEli LillyPhase 3
40
Testosterone Gel 1.62% + Testosterone Gel 1.62%AbbViePhase 1
29
ABT-SLV176AbbViePhase 3
32
AndroGel® + PlaceboAbbVieApproved
43
AndroGel 1.62%AbbVieApproved
43
Recombinant human luteinizing hormone (r-hLH) + Recombinant human follicle-stimulating hormone (r-hFSH) + Human chorionic gonadotropin (hCG)MerckPhase 3
40
Reference: Follitropin alfa + ZoladexMerckPhase 1
29
Testosterone + Alendronate + Placebo Alendronate + Placebo TestosteroneMerckPhase 2
27
Testosterone Enanthate + FinasterideMerckPhase 2
35
Testim 1% (testosterone gel) + PlaceboMerckPhase 2
27
Investigational new drug company code: BGS649 + PlaceboNovartisPhase 2
27
Test formulation + Reference formulationPfizerPhase 1
29
Testosterone ProductBayerPre-clinical
23
Testosterone undecanoate (TU) - NebidoTMBayerPhase 3
37
Testosterone Undeconate (Nebido-R, BAY86-5037)BayerPre-clinical
23
Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
32